To provide further evidence for the control of Hippo‐YAP1 signaling pathway mediated by SOX2 in human ESCC, we characterized SOX2 and YAP1 expression by immunohistochemistry staining in a tissue microarray derived from an ESCC cohort of 101 patients. Here, SOX2 is linked to esophageal squamous cell carcinoma.